Covered recipient · General Payments record
LINDSAY GAETANI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$7,558.50
- Reported across 229 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $772.16 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $154.10 | 1 |
| Abbott Laboratories | $143.43 | 7 |
| Lilly USA, LLC | $140.15 | 10 |
| Insulet Corporation | $84.79 | 3 |
| SANOFI-AVENTIS U.S. LLC | $54.80 | 2 |
| Novo Nordisk AS | $52.27 | 3 |
| DEXCOM, INC. | $44.35 | 2 |
| ABBVIE INC. | $34.14 | 1 |
| RGH ENTERPRISES LLC | $17.57 | 1 |
| IBSA Pharma Inc. | $16.63 | 1 |
| Amgen Inc. | $16.32 | 1 |
| MannKind Corporation | $13.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.80 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312590 | CMS |
| Abbott Laboratories | $23.31 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312592 | CMS |
| Abbott Laboratories | $22.06 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312594 | CMS |
| Abbott Laboratories | $21.11 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312596 | CMS |
| Abbott Laboratories | $23.75 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312598 | CMS |
| Abbott Laboratories | $18.18 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312600 | CMS |
| Abbott Laboratories | $15.22 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312602 | CMS |
| ABBVIE INC. | $34.14 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107141114 | CMS |
| Amgen Inc. | $16.32 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117256139 | CMS |
| Dexcom, Inc. | $20.43 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153374741 | CMS |
| Dexcom, Inc. | $23.92 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153374743 | CMS |
| IBSA Pharma Inc. | $16.63 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980771 | CMS |
| Insulet Corporation | $16.80 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116797031 | CMS |
| Insulet Corporation | $36.63 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116795045 | CMS |
| Insulet Corporation | $31.36 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116795043 | CMS |
| Lilly USA, LLC | $14.45 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752799 | CMS |
| Lilly USA, LLC | $10.88 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135800168 | CMS |
| Lilly USA, LLC | $18.70 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135800170 | CMS |
| Lilly USA, LLC | $12.96 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135791166 | CMS |
| Lilly USA, LLC | $13.01 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752801 | CMS |
| Lilly USA, LLC | $19.63 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135765943 | CMS |
| Lilly USA, LLC | $18.74 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135765945 | CMS |
| Lilly USA, LLC | $18.07 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135740718 | CMS |
| Lilly USA, LLC | $13.33 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135816308 | CMS |
| Lilly USA, LLC | $0.38 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135765941 | CMS |
| Mannkind Corporation | $13.61 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145854560 | CMS |
| Medtronic, Inc. | $154.10 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117002112 | CMS |
| Novo Nordisk Inc | $18.62 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100251812 | CMS |
| Novo Nordisk Inc | $17.13 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100467458 | CMS |
| Novo Nordisk Inc | $16.52 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100574826 | CMS |
| RGH Enterprises LLC | $17.57 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100562753 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.46 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912767 | CMS |
| SANOFI-AVENTIS U.S. LLC | $33.34 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912761 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.